Interpretations of 'appropriate' minority inclusion in clinical research

被引:33
作者
Corbie-Smith, G
Miller, WC
Ransohoff, MF
机构
[1] Univ N Carolina, Dept Social Med, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA
关键词
D O I
10.1016/j.amjmed.2003.09.032
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The range of possible interpretations of the phrase "appropriate representation" has left investigators struggling with the practical application of the National Institutes of Health guidelines on the inclusion of minorities in research. At least three goals might be reached by including minorities in clinical research: to test specific hypotheses about differences by race and ethnicity; to generate hypotheses about possible differences by race and ethnicity; and to ensure the just distribution of the benefits and burdens of participation in research, regardless of whether there are expected differences in outcome by race or ethnicity. In this paper, we describe possible interpretations of "appropriate representation," as well as provide a general approach that investigators might use to address this issue. To expand scientific knowledge about the health of minority populations, investigators should be expected to state which goal they have selected and why that goal is appropriate as compared with other possible goals. (C) 2004 by Excerpta Medica Inc.
引用
收藏
页码:249 / 252
页数:4
相关论文
共 32 条
[1]  
[Anonymous], 1994, NIH GUIDE
[2]   GEOGRAPHICAL INTERRACIAL DIFFERENCES IN POLYMORPHIC DRUG OXIDATION - CURRENT STATE OF KNOWLEDGE OF CYTOCHROMES P450 (CYP) 2D6 AND 2C19 [J].
BERTILSSON, L .
CLINICAL PHARMACOKINETICS, 1995, 29 (03) :192-209
[3]   INCLUSION OF WOMEN AND MINORITIES IN CLINICAL-TRIALS AND THE NIH-REVITALIZATION-ACT OF 1993 - THE PERSPECTIVE OF NIH CLINICAL TRIALISTS - RESPONSE [J].
BOISSEL, JP ;
GUEYFFIER, F ;
HAUGH, M .
CONTROLLED CLINICAL TRIALS, 1995, 16 (05) :286-288
[4]  
BUIST AS, 1995, CONTROL CLIN TRIALS, V16, P296, DOI 10.1016/0197-2456(95)00128-X
[5]   The importance of race and ethnic background in biomedical research and clinical practice [J].
Burchard, EG ;
Ziv, E ;
Coyle, N ;
Gomez, SL ;
Tang, H ;
Karter, AJ ;
Mountain, JL ;
Pérez-Stable, EJ ;
Sheppard, D ;
Risch, N .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (12) :1170-1175
[6]   Race and genomics [J].
Cooper, RS ;
Kaufman, JS ;
Ward, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (12) :1166-1170
[7]   Adequacy of reporting race/ethnicity in clinical trials in areas of health disparities [J].
Corbie-Smith, G ;
St George, DMM ;
Moody-Ayers, S ;
Ransohoff, DF .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2003, 56 (05) :416-420
[8]   What makes clinical research ethical? [J].
Emanuel, EJ ;
Wendler, D ;
Grady, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (20) :2701-2711
[9]  
FREEDMAN LS, 1995, CONTROL CLIN TRIALS, V16, P277, DOI 10.1016/0197-2456(95)00048-8
[10]  
Freeman HP, 1998, CANCER, V82, P219, DOI 10.1002/(SICI)1097-0142(19980101)82:1<219::AID-CNCR27>3.0.CO